Biohaven Pharmaceutical
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -977 | -941 | -948 | |
EBITDA | -176,174 | -331,818 | -181,794 | -151,817 |
EBIT | -178,168 | -333,772 | -182,735 | -152,765 |
Net Income | -160,304 | -319,771 | -179,504 | -144,756 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -141,887 | -170,747 | -103,077 | -115,351 |
Cash | 84,390 | 239,147 | 184,506 | 249,720 |
Basic Shares | 94,372 | 87,766 | 81,601 | 79,929 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $462,509 | $0 |
Gross Profit | -3,369 | -1,386 | 370,845 | -72 |
EBITDA | -429,139 | -462,799 | -217,507 | -114,434 |
EBIT | -436,051 | -464,185 | -218,900 | -114,506 |
Net Income | -408,168 | -570,279 | -213,796 | -118,668 |
Net Change In Cash | 0 | 0 | 462,509 | 0 |
Cost of Revenue | 40,301 | |||
Free Cash Flow | -334,773 | -338,763 | -146,778 | -78,654 |
Cash | 248,402 | 204,877 | 76,057 | 82,506 |
Basic Shares | 71,200 | 44,741 | 39,375 | 39,375 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.74 |
2024-06-30 | -$3.50 |
2024-03-31 | -$2.20 |
2023-12-31 | -$1.81 |
